Interpretive Handbook
‹ Back to index | Back to list | More information
Test 90174:
Bombesin
Clinical Information 
Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test
Bombesin is a 14 amino acid peptide with strong Gastrin and gastric acid
releasing properties. Bombesin also increases pancreatic enzyme output.
Bombesin is found in high concentrations in the lung and has been proposed
as a marker for oat-cell carcinoma. Bombesin hypersecretion has been
associated with several physiological effects including anorexia, hypothermia,
and hyperglycemia. It is also increased in small lung cell carcinoma and
tumors of the APUD series. Bombesin infusion increases Neurotensin,
Gastric Inhibitory Polypeptide and Enteroglucagon levels, but has no effect
on pancreatic Glucagon.
Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.
50-250 pg/mL
This test was developed and its performance characteristics determined by Inter Science Institute. It has not been cleared or approved by the US Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary.
Test Performed by: Inter Science Inst
944 West Hyde Park
Inglewood, CA 90302
External
link
PDF
document
Excel
document
Word
document